(Q33367096)

English

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Kay W Chang

2

0 references

Deborah F. Billmire

8

object named as

Deborah F Billmire

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lindsay Frazier

5

object named as

A Lindsay Frazier

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marcio H Malogolowkin

3

object named as

Marcio Malogolowkin

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

object named as

Wendy B London

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Neyssa Marina

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Richard B Womer

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Frederick Rescorla

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mary M Davis

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Elizabeth J Perlman

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Roger Giller

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stephen J Lauer

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Thomas A Olson

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Children's Oncology Group

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

841-847

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

21 January 2018

Teratomas in childhood: analysis of 142 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Embryonal adenocarcinomas (a type of malignant teratoma) of the sacrococcygeal region.Clinical and pathologic aspects of 21 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Endodermal sinus tumor of the ovary.A clinical and pathologic analysis of 71 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Testicular Cancer in Children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleomycin pulmonary toxicity: Its relationship to renal dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there cumulative or delayed toxicity from cis-platinum?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in children with localized malignant nonseminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cisplatin and etoposide in advanced malignancies of childhood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Grou

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin ototoxicity in children: a practical grading system.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21218

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21218

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33367096&oldid=2185863623"